Document Detail

Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
MedLine Citation:
PMID:  15695125     Owner:  NLM     Status:  MEDLINE    
The effect of body mass index (BMI) on outcomes after coronary artery revascularization remains controversial. We studied 1,203 patients who had multivessel coronary artery disease and underwent stenting (n = 599) or coronary artery bypass grafting (CABG; n = 604) in the Arterial Revascularization Therapies Study. Patients were assigned to 1 of 3 groups according to BMI: <25, 25 to 30, and >30 kg/m(2). At 3-year follow-up, the incidence of death, cerebrovascular events, or myocardial infarction was similar for these BMI categories regardless of the revascularization technique used. Rates of repeat revascularization procedures were significantly higher among patients who had been randomized to stenting but were similar across BMI groups. For patients who had been randomized to undergo CABG, there was a significant decrease in repeat revascularization procedures in obese patients (p = 0.03). Among patients who underwent stenting, BMI had no effect on the 3-year combined end point of rate of major adverse cardiac or cerebrovascular events. Among patients who underwent CABG, major adverse cardiac or cerebrovascular event rates were significantly lower for patients who were obese (11%) or overweight (16%) compared with patients who had a normal BMI (24%; p = 0.008). Thus, in a large cohort of patients who had multivessel coronary artery disease and underwent surgical or percutaneous revascularization, BMI had no effect on 3-year outcome of those who underwent stenting. Conversely, among patients who underwent CABG, those who were overweight or obese had a significantly better outcome than did those who had a normal BMI with regard to survival without major adverse cardiac or cerebrovascular events, mainly due to lower rates of repeat revascularization procedures.
Luis Gruberg; Nestor Mercado; Simcha Milo; Eric Boersma; Clemens Disco; Gerrit-Anne van Es; Pedro A Lemos; Margalit Ben Tzvi; William Wijns; Felix Unger; Rafael Beyar; Patrick W Serruys;
Related Documents :
10576145 - Percutaneous transmyocardial revascularization induces angiogenesis: a histologic and 3...
11409375 - The prognostic value of myocardial viability recognized by low dose dipyridamole echoca...
9236355 - Thoracoscopic transmyocardial laser revascularization.
23727575 - Nf-κb-mediated induction of autophagy in cardiac ischemia/reperfusion injury.
15116245 - Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardi...
8081095 - Electrocardiographic abnormalities after nontraumatic subarachnoid hemorrhage.
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-07     Completed Date:  2005-04-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  439-44     Citation Subset:  AIM; IM    
Division of Invasive Cardiology, Rambam Medical Center, Technion-Israel Institute of Technology, Haifa, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Body Mass Index
Coronary Artery Bypass*
Coronary Disease / mortality,  therapy*
Europe / epidemiology
Middle Aged
Myocardial Infarction / epidemiology
Obesity / epidemiology*
Outcome Assessment (Health Care)*
Reoperation / statistics & numerical data
Stroke / epidemiology
Survival Analysis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The dynamics of plasma transforming growth factor beta 1 (TGF-beta1) level during radiotherapy with ...
Next Document:  Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic ...